Johnson & Johnson
JNJ
#17
Rank
NZ$1.025 T
Marketcap
NZ$425.42
Share price
0.80%
Change (1 day)
48.92%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$19.20

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$19.39. an increase over its 2024 EPS that were of NZ$11.65.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$19.2365.13%
2024NZ$11.65-53.6%
2023NZ$25.10111.16%
2022NZ$11.89-13.84%
2021NZ$13.8041.81%
2020NZ$9.73-18.92%
2019NZ$12.0021.2%
2018NZ$9.901125.3%
2017NZ$0.81-92.23%
2016NZ$10.397.37%
2015NZ$9.68-4.16%
2014NZ$10.1018.1%
2013NZ$8.5524.88%
2012NZ$6.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.53-35.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.37-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.53-66.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.25-67.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$40.07 106.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.59-81.46%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.92-38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.78-23.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.72-34.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.56-66.17%๐Ÿ‡ฌ๐Ÿ‡ง UK